Početna › Skleroderma › Florida
Kliničke studije za Skleroderma u državi Florida
9 studija za Skleroderma traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Millennium Research - Ormond Beach, Ormond Beach
- Integral Rheumatology and Immunology Specialist, Plantation
- BioResearch Partner - South Miami, South Miami
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07497087A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
- IRIS Research and Development LLC, Plantation
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06655155A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Mayo Clinic, Jacksonville
U tijeku regrutacijaFaza 1
Od 18 do 74 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT07085104A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Jacksonville
- GSK Investigational Site, Miami
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT05878717RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Florida, Jacksonville
U tijeku regrutacijaFaza 2/3
Od 18 do 75 godina · Oba spola · Ažurirano 17. kol 2026. · NCT06328777A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Gainesville
- Nkarta Investigational Site, Plantation
U tijeku regrutacijaFaza 1/2
Od 18 do 75 godina · Oba spola · Ažurirano 7. kol 2026. · NCT06733935AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Jupiter, Jupiter
- Artiva Investigational Site Miami, Miami
- Artiva Investigational Site Plantation, Plantation
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 31. srp 2026. · NCT06991114A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Florida, Gainesville
- Nicklaus Children's Hospital, Miami
U tijeku regrutacijaFaza 1
Od 12 do 70 godina · Oba spola · Ažurirano 22. svi 2026. · NCT06308978Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Miami
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 7. svi 2025. · NCT05892614Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.